Sartorius Stedim Biotech Supports ABL Europe in Viral Vector GMP Capacity Expansion

16.03.2018 - ABL Europe has successfully increased and brought online new viral vector manufacturing capacity at its European facility in Strasbourg. A subsidiary of ABL Inc., ABL Europe has...